Replimune Group, Inc. ( REPL) - Key Metrics
REPL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | -$0.77 | -$0.72 | -$0.72 |
| 2026Q2 | ? | -$0.90 | -$0.88 | -$0.90 |
| 2026Q1 | ? | -$0.95 | -$0.84 | -$0.87 |
| 2025Q4 | $0.02 | -$0.92 | -$0.67 | -$0.68 |
| 2025Q3 | ? | -$0.79 | -$0.61 | -$0.63 |
REPL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | -3.16 |
| 2026Q2 | ? | -1.16 |
| 2026Q1 | ? | -2.45 |
| 2025Q4 | ? | -2.65 |
| 2025Q3 | ? | -3.81 |
REPL
Price: $8.88
52 week price:
Earnings Per Share: -3.44 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 354500
Market Capitalization: 782.0 million